358 related articles for article (PubMed ID: 19434742)
1. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography.
Masuzaki R; Tateishi R; Yoshida H; Goto E; Sato T; Ohki T; Imamura J; Goto T; Kanai F; Kato N; Ikeda H; Shiina S; Kawabe T; Omata M
Hepatology; 2009 Jun; 49(6):1954-61. PubMed ID: 19434742
[TBL] [Abstract][Full Text] [Related]
2. Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients.
Wang HM; Hung CH; Lu SN; Chen CH; Lee CM; Hu TH; Wang JH
Liver Int; 2013 May; 33(5):756-61. PubMed ID: 23405889
[TBL] [Abstract][Full Text] [Related]
3. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.
Wong GL; Chan HL; Wong CK; Leung C; Chan CY; Ho PP; Chung VC; Chan ZC; Tse YK; Chim AM; Lau TK; Wong VW
J Hepatol; 2014 Feb; 60(2):339-45. PubMed ID: 24128413
[TBL] [Abstract][Full Text] [Related]
4. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan).
Jung KS; Kim SU; Ahn SH; Park YN; Kim DY; Park JY; Chon CY; Choi EH; Han KH
Hepatology; 2011 Mar; 53(3):885-94. PubMed ID: 21319193
[TBL] [Abstract][Full Text] [Related]
5. Liver stiffness measurement in patients with cirrhosis and hepatocellular carcinoma: a case-control study.
Nahon P; Kettaneh A; Lemoine M; Seror O; Barget N; Trinchet JC; Beaugrand M; Ganne-Carrié N
Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):214-9. PubMed ID: 19212210
[TBL] [Abstract][Full Text] [Related]
6. Baseline and serial liver stiffness measurement in prediction of portal hypertension progression for patients with compensated cirrhosis.
Wang JH; Chuah SK; Lu SN; Hung CH; Kuo CM; Tai WC; Chiou SS
Liver Int; 2014 Oct; 34(9):1340-8. PubMed ID: 24620731
[TBL] [Abstract][Full Text] [Related]
7. The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B.
Chon YE; Jung ES; Park JY; Kim DY; Ahn SH; Han KH; Chon CY; Jung KS; Kim SU
J Clin Gastroenterol; 2012 Jul; 46(6):518-25. PubMed ID: 22688146
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis.
Petta S; Cammà C; DI Marco V; Calvaruso V; Enea M; Bronte F; Butera G; Cabibi D; Craxì A
Aliment Pharmacol Ther; 2009 Sep; 30(6):603-13. PubMed ID: 19563503
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the risk of hepatocellular carcinoma in patients with prominently elevated liver stiffness measurements by FibroScan: a multicentre study.
Adler M; Larocca L; Trovato FM; Marcinkowski H; Pasha Y; Taylor-Robinson SD
HPB (Oxford); 2016 Aug; 18(8):678-83. PubMed ID: 27485062
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of liver stiffness for hepatocellular carcinoma and mortality in HBeAg-negative chronic hepatitis B.
Fung J; Lai CL; Seto WK; Wong DK; Yuen MF
J Viral Hepat; 2011 Oct; 18(10):738-44. PubMed ID: 20659306
[TBL] [Abstract][Full Text] [Related]
11. Outreach screening of drug users for cirrhosis with transient elastography.
Moessner BK; Jørgensen TR; Skamling M; Vyberg M; Junker P; Pedersen C; Christensen PB
Addiction; 2011 May; 106(5):970-6. PubMed ID: 21182552
[TBL] [Abstract][Full Text] [Related]
12. Liver stiffness-based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapy.
Wang JH; Yen YH; Yao CC; Hung CH; Chen CH; Hu TH; Lee CM; Lu SN
Liver Int; 2016 Dec; 36(12):1793-1799. PubMed ID: 27254286
[TBL] [Abstract][Full Text] [Related]
13. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
[TBL] [Abstract][Full Text] [Related]
14. Liver Stiffness Measurement and Risk Prediction of Hepatocellular Carcinoma After HCV Eradication in Veterans With Cirrhosis.
John BV; Dang Y; Kaplan DE; Jou JH; Taddei TH; Spector SA; Martin P; Bastaich DR; Chao HH; Dahman B
Clin Gastroenterol Hepatol; 2024 Apr; 22(4):778-788.e7. PubMed ID: 38061410
[TBL] [Abstract][Full Text] [Related]
15. Prediction of liver stiffness hepatocellular carcinoma in chronic hepatitis C patients on interferon-based anti-viral therapy.
Narita Y; Genda T; Tsuzura H; Sato S; Kanemitsu Y; Ishikawa S; Kikuchi T; Hirano K; Iijima K; Wada R; Ichida T
J Gastroenterol Hepatol; 2014 Jan; 29(1):137-43. PubMed ID: 24117602
[TBL] [Abstract][Full Text] [Related]
16. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
17. Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients.
Macías J; Camacho A; Von Wichmann MA; López-Cortés LF; Ortega E; Tural C; Ríos MJ; Merino D; Téllez F; Márquez M; Mancebo M; Pineda JA
AIDS; 2013 Oct; 27(16):2541-9. PubMed ID: 23736148
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.
Ziol M; Handra-Luca A; Kettaneh A; Christidis C; Mal F; Kazemi F; de Lédinghen V; Marcellin P; Dhumeaux D; Trinchet JC; Beaugrand M
Hepatology; 2005 Jan; 41(1):48-54. PubMed ID: 15690481
[TBL] [Abstract][Full Text] [Related]
19. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
[TBL] [Abstract][Full Text] [Related]
20. Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term.
Macías J; Mancebo M; Márquez M; Merino D; Téllez F; Rivero A; von Wichmann MA; López-Cortés LF; Merchante N; Santos J; Raffo M; Pérez-Pérez M; Camacho Á; Iribarren JA; Pineda JA
Hepatology; 2015 May; 61(5):1503-11. PubMed ID: 25545020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
